Breast adipocyte size associates with ipsilateral invasive breast cancer risk after ductal carcinoma in situ
Mathilde M. Almekinders(The Netherlands Cancer Institute), Jelle Wesseling(Leiden University Medical Center)
Cited by 26
Related Papers
(untitled)
|Edinburgh Research Explorer|0|353
Magnetic Resonance Imaging Response Monitoring of Breast Cancer During Neoadjuvant Chemotherapy: Relevance of Breast Cancer Subtype
|Journal of Clinical Oncology|2011|306
Use of 70-gene signature to predict prognosis of patients with node-negative breast cancer: a prospective community-based feasibility study (RASTER)
|The Lancet Oncology|2007|278
The 70-gene signature as a response predictor for neoadjuvant chemotherapy in breast cancer
|Breast Cancer Research and Treatment|2009|256
Triple-negative breast cancer: BRCAness and concordance of clinical features with BRCA1-mutation carriers
|British Journal of Cancer|2013|241